Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Shenzhen Chipscreen Biosciences Co

688321
Current price
22.36 CNY -0.93 CNY (-3.99%)
Last closed 23 CNY
ISIN CNE100003LW0
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Exchange Shanghai Stock Exchange
Capitalization 9 757 672 637 CNY
Yield for 12 month -2.49 %
1Y
3Y
5Y
10Y
15Y
688321
21.11.2021 - 28.11.2021

Shenzhen Chipscreen Biosciences Co., Ltd. engages in the research, development, and sale of original small molecule drugs. The company develops precursor compounds and original new drug product lines for the treatment of human diseases in five therapeutic areas, including cancer, metabolic diseases, autoimmune disorders, central nervous system disorders, and antivirals. It is developing chidamide, a subtype-selective benzamide inhibitor of histone deacetylase (HDAC) primarily targeting subtypes 1, 2, 3 of class I HDAC; chiglitazar, a new-generation insulin sensitizing candidate drug for the treatment of type 2 diabetes mellitus; chiauranib, an aurora B/VEGFR/PDGFR /c-Kit/CSF1R inhibitor; and CS12192, a highly selective JAK3 kinase inhibitor. Shenzhen Chipscreen Biosciences Co., Ltd. was founded in 2001 and is headquartered in Shenzhen, China. Address: Zhigu Industrial Park, Shenzhen, China, 518057

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

228.35 CNY

P/E ratio

Dividend Yield

Current Year

+523 225 356 CNY

Last Year

+529 448 877 CNY

Current Quarter

+171 397 506 CNY

Last Quarter

+130 483 268 CNY

Current Year

+466 309 350 CNY

Last Year

+499 484 818 CNY

Current Quarter

+149 757 451 CNY

Last Quarter

+115 640 789 CNY

Key Figures 688321

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -39 518 606 CNY
Operating Margin TTM -7.57 %
PE Ratio
Return On Assets TTM -1.65 %
PEG Ratio
Return On Equity TTM -6.28 %
Wall Street Target Price 228.35 CNY
Revenue TTM 583 725 919 CNY
Book Value 4.05 CNY
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 27 %
Dividend Yield
Gross Profit TTM 532 968 337 CNY
Earnings per share -0.26 CNY
Diluted Eps TTM -0.26 CNY
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY 34.3 %
Profit Margin -18.46 %

Dividend Analytics 688321

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History 688321

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation 688321

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 17.7817
Price Sales TTM 16.8628
Enterprise Value EBITDA 50.8375
Price Book MRQ 5.904

Financials 688321

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators 688321

For 52 weeks

12.46 CNY 25.23 CNY
50 Day MA 18.12 CNY
Shares Short Prior Month
200 Day MA 18.76 CNY
Short Ratio
Shares Short
Short Percent